Quantcast

Latest stroke Stories

2014-08-28 12:29:37

BOSTON, Aug. 28, 2014 /PRNewswire/ -- The North American Thrombosis Forum (NATF), a non-profit organization dedicated to increasing public awareness of thrombosis and related cardiovascular diseases, is thrilled to welcome 7 renowned experts in cardiovascular medicine to speak at their Fall educational program, the 8(th) Annual Thrombosis Summit, on Saturday, September 20. The Thrombosis Summit will take place at the beautiful Fairmont Copley Plaza Hotel located in Copley Square in...

2014-08-27 23:14:37

The second annual Brain Aneurysm Awareness Run (BAAR) will take place in Wayne, PA on Saturday, September 6, 2014. All proceeds benefit the world renowned Brain Aneurysm Foundation. Hanover, MA (PRWEB) August 27, 2014 As part of the ongoing effort to increase awareness of brain aneurysms, organizers of last year’s very successful Brain Aneurysm Awareness Run (BAAR) have scheduled their 2nd annual event to take place on Saturday, September 6, 2014 in Wayne, Pennsylvania. Founded in 2013...

2014-08-27 23:12:45

A study released August 1 highlights the challenges related to managing anticoagulant–associated intracerebral hemorrhage (AAICH). Washington, D.C. (PRWEB) August 27, 2014 A recently published study by the Journal of Neurosurgery discusses the importance of time in correcting coagulopathy to prevent permanent injury or death. The study focuses on a variety of anticoagulants and examines medical conditions alleged to be caused by these drugs. According to the research, although...

2014-08-25 08:27:37

-- Results from X-VeRT, the first prospective exploratory study of a Factor Xa inhibitor in patients with atrial fibrillation undergoing cardioversion, will be presented during an ESC Congress 2014 Hot Line Session RARITAN, N.J., Aug. 25, 2014 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen) announced today that results from the Phase 3b exploratory X-VeRT study, investigating the oral Factor Xa inhibitor XARELTO(®) (rivaroxaban) in patients with non-valvular atrial...

2014-08-25 08:27:31

Hot Line session presentations to feature renal function data from pivotal RE-LY® trial and global GLORIA(TM)-AF registry updates RIDGEFIELD, Conn., Aug. 25, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. today announced that data from nine company-sponsored Pradaxa® (dabigatran etexilate mesylate) studies will be presented at the European Society of Cardiology (ESC) Congress 2014, August 30 to September 3 in Barcelona, Spain. The abstracts will feature data about the use...

sick child
2014-08-24 05:25:27

Eric Hopton for redOrbit.com - Your Universe Online Although the risk of stroke is generally thought to increase with age, the disease can occur at any time of life. The incidence of stroke in children, however, is very low. Only around five children in every 100,000 experience a stroke. Previous research among adult stroke patients has established that, among the factors that increase the risk of stroke, infections can play a major role. New findings have revealed that this heightened...

Scientists Find That Targeted Brain Stimulation Aids Stroke Recovery In Mice
2014-08-21 03:19:57

By Bruce Goldman, Stanford University Medical Center When investigators at the Stanford University School of Medicine applied light-driven stimulation to nerve cells in the brains of mice that had suffered strokes several days earlier, the mice showed significantly greater recovery in motor ability than mice that had experienced strokes but whose brains weren't stimulated. These findings, which will be published online Aug. 18 in Proceedings of the National Academy of Sciences, could...

Fenofibrate for diabetic women
2014-08-21 03:00:45

Dan Gafney, University of Sydney The cholesterol-lowering drug fenofibrate cuts cardiovascular disease risks by 30 percent in women with type-2 diabetes, a new University of Sydney study reveals. "The finding is good news for women," says the study's chairman, University of Sydney Professor, Tony Keech. "The study shows that fenofibrate reduced the risk of dying from cardiovascular disease, or having a stroke or other adverse cardiovascular event by 30 percent in women and 13 percent...

2014-08-20 23:07:40

Randy Fenninger to Lead Organization With Strategic Focus Aimed at Increasing Recognition of Life-Threatening Blood Clots and Their Impact on Public Health Rockville, MD (PRWEB) August 20, 2014 The National Blood Clot Alliance (NBCA), a nonprofit advocacy organization dedicated to advancing the prevention, early diagnosis and successful treatment of life-threatening blood clots, announces the appointment of Randy Fenninger, JD, as its new Chief Executive Officer (CEO). Fenninger, who...

heart thinkstock 452128839
2014-08-20 03:30:48

American Heart Association Rapid Access Journal Report U.S. hospitalizations and deaths from heart disease and stroke dropped significantly in the last decade, according to new research in the American Heart Association journal Circulation. “Interestingly, these improvements happened in a period when there were no real ‘miracle’ clinical advancements,” said Harlan Krumholz, M.D., S.M., lead author of the “most comprehensive report card to-date” on America’s progress in...


Latest stroke Reference Libraries

Stroke
2012-05-02 19:35:56

Stroke is a peer-reviewed medical journal published monthly by Lippincott Williams & Wilkins on behalf of the American Heart Association. As of May 2012, the current editor-in-chief is Marc Fisher (University of Massachusetts Medical School). Stroke covers research on cerebral circulation and related diseases, including clinical research on assessment of risk for stroke, diagnosis, prevention, and treatment, as well as rehabilitation. The audience base for Stroke includes neurologists,...

More Articles (1 articles) »
Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related